DAS DEUTSCH-LUXEMBURGISCHE ABWASSERKLAERWERK ECHTERNACH-WEILERBACH AN DER SAUER. = LA STATION D'EPURATION GERMANO-LUXEMBOURGEOISE D'ECHTERNACH-WEILERBACH SUR LE SAUERMEURER R.1978; WASS. U. BODEN; DTSCH.; DA. 1978; VOL. 30; NO 5; PP. 111-115Article

DER AUSBAU DER SAAR ZUR GROSSSCHIFFAHRTSSTRASSE AN DER SICHT DES LANDES RHEINLAND-PFALZ = L'AMENAGEMENT DE LA SARRE EN GRANDE VOIE DE NAVIGATION DU POINT DE VUE DE LA REGION RHENANIE PALATINATMEURER R.1979; WASS. U. BODEN; DEU; DA. 1979; VOL. 31; NO 4; PP. 96-101; ABS. ENG; BIBL. 4 REF.Article

Aspekte der Landespflege und der Gewässergüte beim Saarausbau in Rheinland-Pfalz - eine Zwischenbilanz = Aspects de la préservation du territoire et de la qualité des eaux dans l'aménagement de la Sarre en Rhénanie-Palatinat: un bilan intermédiaire = Aspects of environment control and water quality during the development of the Saar in Rhineland-Palatinate - an interim reportMEURER, R.Wasser und Boden. 1985, Vol 37, Num 12, pp 607-611, issn 0043-0951Article

Lebensmittelverträglicher und umweltschonender Düngemitteleinsatz in Landwirtschaft und Weinbau = Fertilizer utilization in agriculture and wine-growing, acceptable to food production and environmentMEURER, R.Wasser und Boden. 1991, Vol 43, Num 2, pp 77-81, issn 0043-0951Article

Fortschritte beim Ausbau der Saar = Progrès dans l'aménagement de la rivière Sarre = River Saar waterway construction making progressMEURER, R.Wasserwirtschaft. 1987, Vol 77, Num 12, pp 635-640, issn 0043-0978Article

Lack of effect of pertussis toxin on TNF-α-induced formation of reactive oxygen intermediates by human neutrophilsMEURER, R; MACINTYRE, D. E.Biochemical and biophysical research communications (Print). 1989, Vol 159, Num 2, pp 763-769, issn 0006-291XArticle

Effects of cyclooxygenase and lipoxygenase inhibitors on inflammation associated with oxazolone-induced delayed hypersensitivityMEURER, R; OPAS, E. E; HUMES, J. L et al.Biochemical pharmacology. 1988, Vol 37, Num 18, pp 3511-3514, issn 0006-2952, 4 p.Conference Paper

A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the ratGOLDENBERG, M. M; MEURER, R. D.Prostaglandins. 1984, Vol 28, Num 2, pp 271-278, issn 0090-6980Article

Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L634,549, in tissue culture and miceMURRAY, P. K; HABBERSETT, M. C; MEURER, R. D et al.The American journal of tropical medicine and hygiene. 1983, Vol 32, Num 6, pp 1242-1250, issn 0002-9637Article

The role of CD18 in IL-8 induced dermal and synovial inflammationFORREST, M. J; EIERMANN, G. J; MEURER, R et al.British journal of pharmacology. 1992, Vol 106, Num 2, pp 287-294, issn 0007-1188Article

Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumoursALEIXO, P. B; HARTMANN, A. A; MENEZES, I. C et al.Journal of clinical pathology. 2009, Vol 62, Num 12, pp 1127-1135, issn 0021-9746, 9 p.Article

Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1VAN RIPER, G; SICILIANO, S; FISCHER, P. A et al.The Journal of experimental medicine. 1993, Vol 177, Num 3, pp 851-856, issn 0022-1007Article

Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by inejection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1α, or human interleukin 8MEURER, R; VAN RIPER, G; FEENEY, W et al.The Journal of experimental medicine. 1993, Vol 178, Num 6, pp 1913-1921, issn 0022-1007Article

Pharmacology fo the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)benzo(b)thiophene-2-carboxamideBAILEY, P. J; DALLOB, A. L; ROSA, R et al.Arzneimittel-Forschung. 1988, Vol 38, Num 3, pp 372-378, issn 0004-4172Article

Biochemical and biological activities of 2,3-dihydro-6-[3-(2-hydroxymethyl)phenyl-2-propenyl]-5-benzofuranol (L-651,896), a novel topical anti-inflammatory agentBONNEY, R. J; DAVIES, P; ZAMBIAS, R et al.Biochemical pharmacology. 1987, Vol 36, Num 22, pp 3885-3891, issn 0006-2952Article

5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitorsEVANS, J. F; LEVEILLE, C; LUELL, S et al.Molecular pharmacology. 1991, Vol 40, Num 1, pp 22-27, issn 0026-895XArticle

L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3-methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitorBELANGER, P; MAYCOCK, A; LETTS, L. G et al.Canadian journal of physiology and pharmacology. 1987, Vol 65, Num 12, pp 2441-2448, issn 0008-4212Article

L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorGILLARD, J; FORD-HUTCHINSON, A. W; PIECHUTA, H et al.Canadian journal of physiology and pharmacology. 1989, Vol 67, Num 5, pp 456-464, issn 0008-4212, 9 p.Article

Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224LAU, C. K; BELANGER, P. C; FORD-HUTCHINSON, A. W et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 6, pp 1190-1197, issn 0022-2623, 8 p.Article

Substituted 2-aminopyridines as inhibitors of nitric oxide synthasesHAGMANN, W. K; CALDWELL, C. G; CHABIN, R. M et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 17, pp 1975-1978, issn 0960-894XArticle

Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequencesSINGER, I. I; KAWKA, D. W; FORREST, M. J et al.The Journal of immunology (1950). 1993, Vol 150, Num 7, pp 2844-2857, issn 0022-1767Article

Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3-hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterGIROTRA, N. N; BIFTU, T; DAVIES, P et al.Journal of medicinal chemistry (Print). 1992, Vol 35, Num 19, pp 3474-3482, issn 0022-2623Article